Modulation of Human CXCL12 Binding Properties to Glycosaminoglycans To Enhance Chemotactic Gradients
- 26 August 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 5 (10) , 5128-5138
Abstract
Controlled release of active biomolecules is an attractive approach to modulate chemotactic gradients and accordingly the recruitment of cells, e.g. endothelial progenitor cells to improve wound healing or stimulate angiogenesis after myocardial infarction. Here, we developed variants of hCXCL12, also named stromal cell-derived factor 1α, a chemokine that activates the CXCR4 and consequently recruits tissue specific stem and progenitor cells. hCXCL12 variants were designed to bind to glycosaminoglycans (GAGs) with different affinities in order to modulate its release. 16 analogs were recombinantly produced, characterized and tested for their GAG-binding property. The most promising variants hCXCL12 K24/K27/R41/R47A and hCXCL12 Q48K were used for release studies from starPEG-heparin-hydrogels. The reduced GAG affinity led to a fast release of hCXCL12 K24/K27/R41/R47A, whereas hCXCL12 Q48K was slowly released over two weeks due to its increased binding strength compared to wild type hCXCL12. Migration of Jurkat cells and early endothelial progenitor cells was proven to demonstrate the applicability of the approach to endogenously CXCR4 expressing cell types. Thus, this work offers new options for enhancing chemotactic hCXCL12 gradients by a combination of native and modified hCXCL12 variants to improve and prolong the recruitment of CXCR4-positive stem and progenitor cells to injured sites.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (FR 3367/2-1, TRR 67)
This publication has 63 references indexed in Scilit:
- Signaling properties of the human chemokine receptors CXCR4 and CXCR7 by cellular electric impedance measurementsPLOS ONE, 2017
- Comparing trends in mortality from cardiovascular disease and cancer in the United Kingdom, 1983–2013: joinpoint regression analysisPopulation Health Metrics, 2017
- International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine ReceptorsPharmacological Reviews, 2014
- Estimating Deaths From Cardiovascular Disease: A Review of Global Methodologies of Mortality MeasurementCirculation, 2013
- Monomeric structure of the cardioprotective chemokine SDF‐1/CXCL12Protein Science, 2009
- Vascular repair by endothelial progenitor cellsCardiovascular Research, 2008
- Hypoxia-Induced Mediators of Stem/Progenitor Cell Trafficking Are Increased in Children With HemangiomaArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cellsBlood, 2004
- Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1Nature Medicine, 2004
- Stromal Cell–Derived Factor-1 Effects on Ex Vivo Expanded Endothelial Progenitor Cell Recruitment for Ischemic NeovascularizationCirculation, 2003